<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35">
 <label>35.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gutjahr</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Papagno</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Nicoli</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Lamoureux</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Vernejoul</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Lioux</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Cutting edge: a dual TLR2 and TLR7 ligand induces highly potent humoral and cell-mediated immune responses</article-title>. 
  <source>J Immunol.</source> (
  <year>2017</year>) 
  <volume>198</volume>:
  <fpage>4205</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.4049/jimmunol.1602131</pub-id>
  <?supplied-pmid 28432147?>
  <pub-id pub-id-type="pmid">28432147</pub-id>
 </mixed-citation>
</ref>
